Skip to main content

What the FDA labels say about taking them together

Naldemedine and ritonavir

Naldemedine's FDA label of July 25, 2025 names ritonavir in its drug interactions section; the ritonavir label PlainMeds reads does not name naldemedine. The naldemedine label: “Moderate and Strong CYP3A Inhibitors Clinical Impact Increase in plasma naldemedine concentrations Intervention Monitor for potential naldemedine-related adverse reactions.”

Check it at the source: the naldemedine FDA label on DailyMed (effective July 25, 2025, BioDelivery Sciences International Inc); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the naldemedine label say about ritonavir?

Naldemedine label, drug interactions

Moderate (e.g., fluconazole, atazanavir, aprepitant, diltiazem, erythromycin) and Strong (e.g., itraconazole, ketoconazole, clarithromycin, ritonavir, saquinavir) CYP3A Inhibitors Clinical Impact Increase in plasma naldemedine concentrations [see Clinical Pharmacology (12.3) ] Intervention Monitor for potential naldemedine-related adverse reactions [see Adverse Reactions (6.1) ].

Source: FDA drug label (SYMPROIC), NDA208854 (Bdsi), as published by BioDelivery Sciences International Inc, effective July 25, 2025 (SPL set b1a1256c-a1eb-4abe-ab1e-30e4711afd16), via openFDA; the full label on DailyMed

What does the ritonavir label say about naldemedine?

Ritonavir's label (effective July 23, 2026) does not name naldemedine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Naldemedine generic labelers
7Ritonavir generic labelers
NaldemedineRitonavir
Labeled forn/aHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$16.26 per tablet 0.2 mg tablet$0.607 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?